Search Within

Robert Motzer

Formats
  1. Journal Article (609)
  2. Meeting Abstract (577)
  3. Book Section (20)
  4. Review (13)
  5. Conference Paper (6)
  6. Correspondence (6)
  7. Guidelines (5)
  8. Research Letter (5)
  9. Editorial (3)
  10. Book Whole (2)
Groups
  1. Department of Medicine (1246)
  2. Genitourinary Oncology Service (1246)
  3. Solid Tumor Oncology Division (1246)
  4. Surgery (290)
  5. Urology (281)
  6. Survivorship Research (253)

More Groups

People
  1. George Bosl (182)
  2. Martin Voss (178)
  3. Darren Feldman (158)
  4. Dean Bajorin (128)
  5. Paul Russo (119)
  6. Joel Sheinfeld (110)

More People

Years
  1. 2025 (29)
  2. 2024 (49)
  3. 2023 (47)
  4. 2022 (64)
  5. 2021 (65)
  6. 2020 (65)

More Years

Publications
  1. Journal of Clinical Oncology (447)
  2. Annals of Oncology (81)
  3. BJU International (40)
  4. Cancer (35)
  5. European Journal of Cancer (34)
  6. Clinical Cancer Research (33)

More Publications

Publishers
  1. American Society of Clinical Oncology (450)
  2. Elsevier Science, Inc. (111)
  3. Oxford University Press (111)
  4. Elsevier Inc. (89)
  5. Wiley Blackwell (86)
  6. American Association for Cancer Research (58)

More Publishers

Results (1246)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
    Journal Article

    Motzer, R. J.; Hutson, T. E.; Tomczak, P.; Michaelson, D.; Bukowski, R. M.; Rixe, O.; Oudard, S.; Negrier, S.; Szczylik, C.; Kim, S. T.; more...
    New England Journal of Medicine (2007)

    Fulltext@MSK | Save
  • Efficacy and safety of sunitinib as second-line therapy in patients with metastatic renal cell carcinoma
    Journal Article

    Motzer, R. J.; Feldman, D. R.; Baum, M. S.; Ginsberg, M.
    American Journal of Hematology/Oncology (2007)

    Fulltext@MSK | Save
  • Phase I/II trial of temsirolimus combined with interferon alfa for advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; Hudes, G. R.; Curti, B. D.; McDermott, D. F.; Escudier, B. J.; Negrier, S.; Duclos, B.; Moore, L.; O'Toole, T.; Boni, J. P.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Sunitinib and hypothyroidism - The author replies
    Journal Article

    Motzer, R. J.
    New England Journal of Medicine (2007)

    Fulltext@MSK | Save
  • Targeted drugs for metastatic renal cell carcinoma
    Journal Article

    Motzer, R. J.; Basch, E.
    Lancet (2007)

    Fulltext@MSK | Save
  • Interferon-α resistance associated genes in renal cell carcinoma identified by expression profiling
    Journal Article

    Korkola, J. E.; Kondagunta, G. V.; Reuter, V. E.; Motzer, R. J.; Chaganti, R. S. K.
    Journal of Urology (2007)

    Fulltext@MSK | Save
  • Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors
    Journal Article

    Kondagunta, G. V.; Bacik, J.; Sheinfeld, J.; Bajorin, D.; Bains, M.; Reich, L.; Deluca, J.; Budnick, A.; Ishill, N.; Mazumdar, M.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
    Journal Article

    Hudes, G.; Carducci, M.; Tomczak, P.; Dutcher, J.; Figlin, R.; Kapoor, A.; Staroslawska, E.; Sosman, J.; McDermott, D.; Bodrogi, I.; more...
    New England Journal of Medicine (2007)

    Fulltext@MSK | Save
  • Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib
    Journal Article

    Feldman, D. R.; Martorella, A. J.; Robbins, R. J.; Motzer, R. J.
    JNCI: Journal of the National Cancer Institute (2007)

    Fulltext@MSK | Save
  • Phase III randomized trial in patients with poor-prognosis metastatic germ cell tumors
    Journal Article

    Feldman, D. R.; Motzer, R. J.
    American Journal of Hematology/Oncology (2007)

    Fulltext@MSK | Save